![Mark McDonnell](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Mark McDonnell
No open positions remaining
Health Technology
Profile
Mark McDonnell worked as Chief Chemist at Neuropathix, Inc. Former job includes Chief Chemist at Neuropathix, Inc.
Former positions of Mark McDonnell
| Companies | Position | End |
|---|---|---|
| NEUROPATHIX, INC. | Corporate Officer/Principal | 01/09/2024 |
Experiences
Positions held
Active
Inactive
Listed companies
Private companies
Linked companies
| Private companies | 1 |
|---|---|
Neuropathix, Inc.
 Neuropathix, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company that discovers, develops and commercializes therapeutics for inflammatory & neuropathic pain related diseases | Health Technology |
- Stock Market
- Insiders
- Mark McDonnell
